Inflammatory Lesion Count

WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of new imaging techniques and presented at ACTRIMS.

A dermocosmetic containing salicylic acid may be used as an adjunct therapy to benzoyl peroxide to reduce the negative effects of prolonged benzoyl peroxide use, according to a study.